Literature DB >> 7487498

Cloning and restriction endonuclease mapping of herpes simplex virus type-1 strains H129 and +GC.

T E Kienzle1, J S Henkel, J Y Ling, M C Banks, D R Beers, B Jones, W G Stroop.   

Abstract

EcoRI fragments of herpes simplex virus I (HSV-1) strains H129 and +GC were cloned and the EcoRI and BglII restriction enzyme sites were mapped. Comparison of these enzyme sites with the sequence of HSV-1 strain 17syn+ demonstrated that all EcoRI sites were identical. For H129, the BglII sites were also found to match strain 17syn+ BglII sites. With one exception, the BglII sites in strain +GC also aligned with the strain 17syn+ sequence. The one exception was a missing BglII site from strain +GC located between bases 25,149 and 25,154 in the EcoRI D fragment within the viral deoxyribonuclease gene (UL12). The BglII site represents the first difference to be mapped within HSV-1 strains H129 and +GC which have unique pathobiological properties in animal models of acute and reactivated infections.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7487498     DOI: 10.1007/bf01322540

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  37 in total

1.  Complete DNA sequence of the short repeat region in the genome of herpes simplex virus type 1.

Authors:  D J McGeoch; A Dolan; S Donald; D H Brauer
Journal:  Nucleic Acids Res       Date:  1986-02-25       Impact factor: 16.971

Review 2.  Herpes simplex virus encephalitis of the human adult: reactivation of latent brain infection.

Authors:  W G Stroop
Journal:  Pathol Immunopathol Res       Date:  1986

3.  Neurovirulence in an experimental focal herpes encephalitis: relationship to observed seizures.

Authors:  M Schlitt; A P Bucher; W G Stroop; F Pindak; F O Bastian; R A Jennings; A D Lakeman; R J Whitley
Journal:  Brain Res       Date:  1988-02-09       Impact factor: 3.252

4.  Herpes simplex virus type 1 strain KOS-63 does not cause acute or recurrent ocular disease and does not reactivate ganglionic latency in vivo.

Authors:  W G Stroop; M C Banks
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

5.  Genomic sequencing.

Authors:  G M Church; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

6.  Two avirulent herpes simplex viruses generate lethal recombinants in vivo.

Authors:  R T Javier; F Sedarati; J G Stevens
Journal:  Science       Date:  1986-11-07       Impact factor: 47.728

7.  A sequence in HpaI-P fragment of herpes simplex virus-1 DNA determines intraperitoneal virulence in mice.

Authors:  Y Becker; J Hadar; E Tabor; T Ben-Hur; I Raibstein; A Rösen; G Darai
Journal:  Virology       Date:  1986-03       Impact factor: 3.616

8.  The herpes simplex virus type 1 alkaline nuclease is not essential for viral DNA synthesis: isolation and characterization of a lacZ insertion mutant.

Authors:  S K Weller; M R Seghatoleslami; L Shao; D Rowse; E P Carmichael
Journal:  J Gen Virol       Date:  1990-12       Impact factor: 3.891

9.  Biological characterization of a herpes simplex virus intertypic recombinant which is completely and specifically non-neurovirulent.

Authors:  R L Thompson; J G Stevens
Journal:  Virology       Date:  1983-11       Impact factor: 3.616

10.  HSV-1 thymidine kinase promotes virulence and latency in the mouse.

Authors:  Y J Gordon; D M Gilden; Y Becker
Journal:  Invest Ophthalmol Vis Sci       Date:  1983-05       Impact factor: 4.799

View more
  1 in total

1.  Sequence variability in clinical and laboratory isolates of herpes simplex virus 1 reveals new mutations.

Authors:  Moriah L Szpara; Lance Parsons; L W Enquist
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.